Antifungal Flashcards
AMPHOTERACIN
Amphotericin B is a naturally occurring polyene
antifungal produced by Streptomyces nodosus
MECHANISM OF ACTION
Amphoteracin
Amphotericin B binds to ergosterol in the plasma membranes of fungal cells.
it forms pores
require hydrophobic interactions between the lipophilic
segment of the polyene antifungal and the sterol
pores disrupt membrane function, allowing electrolytes AND small molecules to leak from the cell,
resulting in cell death
Spectrum of amphoteracin
static or cidal
unique feature
fungicidal or fungistatic
Candida albicans, Histoplasma capsulatum, Cryptococcus
neoformans, Coccidioides immitis, Blastomyces dermatitidis, and
many strains of Aspergillus
Amphotericin B is also used in
the treatment of the protozoal infection leishmaniasis.
KINETICS amphoteracin
IV INFUSION
INSOLUBLE IN WATER
coformulated with sodium deoxycholate (conventional) or artificial lipids to form liposomes.
extensively bound to plasma
proteins and is distributed throughout the body.
ittle of the drug is
found in the cerebrospinal fluid (CSF), vitreous humor, peritoneal
fluid, or synovial fluid.
ADRS AMPHOTERACIN
FEVER AND CHILLS/ANTIPYRETIC OR
RENAL TOXICITY
a decrease in glomerular filtration rate and renal tubular function. Serum creatinine may
increase, creatinine clearance can decrease, and potassium
and magnesium are lost.
Sodium loading with infusions of normal saline prior to administration of the conventional formulation or use of the liposomal
amphotericin B products minimize the risk of nephrotoxicity.
SUDDEN DROP IN BLOOD PRESSURE DUE TO IV INFUSION
Flucytosine
a synthetic pyrimidine antimetabolite that is often used in combination with other antifungal age
mechanism of action FLUCYSTOSINE
5-FC enters the fungal cell via a cytosine-specific permease, an enzyme not found in mammalian cells.
It is subsequently converted to a series of compounds, including 5-fluorouracil (5-FU) and 5-fluorodeoxyuridine 5′-monophosphate,
which disrupt nucleic acid and protein synthesis
Spectrum flucystosine
Fungistatic.
effective in combination with itraconazole for treating chromoblastomycosis
combination with amphotericin B for the treatment of
systemic mycoses and meningitis caused by C. neoformans
and C. Albicans.
USED FOR Candida UTI INFECTION WHERE FLUCONAZOLE IS NOT EFFECTIVE.
kinetic of flucystosin
well absorbed
disribute and penetrates well
dose adjustment in renal compromised patients
ADRS OF FLUCYSTOSINE
NEUTROPENIA
THROMBOCYTOPENIA
BONE MARROW DEPRESSION
griseofulvin
why use is stopped
speectrum
absorption
contra indication
ADRS
causes disruption of the mitotic
spindle and inhibition of fungal mitosis
Replaced by terbinafine, still for treatment of onychomycosis, although it is still used for dermatophytosis of the scalp and hair
py is dependent on the rate of replacement of healthy skin and
nails.
Ultrafine crystalline preparations are absorbed adequately from
the gastrointestinal tract, and absorption is enhanced by high-fat .
Griseofulvin induces hepatic CYP450 activity, which increases the
rate of metabolism of a number of drugs, including anticoagulants.
The use of griseofulvin is contraindicated in pregnancy and patients
with porphyria.
meals.
. Nystatin
why it is administed parentally
spectrum
absorption
why it is not used parentally
how it resembles to amphoteracin B
Nystatin is a polyene antifungal, and its structure,
chemistry, mechanism of action, and resistance profile resemble
those of amphotericin B. It is used for the treatment of cutaneous
and oral Candida infections. The drug is negligibly absorbed from
the gastrointestinal tract, and it is not used parenterally due to systemic toxicity (acute infusion-related adverse effects and nephrotoxicity). It is administered as an oral agent (“swish and swallow”
or “swish and spit”) for the treatment of oropharyngeal candidiasis
(thrush), intravaginally for vulvovaginal candidiasis, or topically for
cutaneous candidiasis.
RESISTANCE TO AMPHOTERACIN AND FLUCYSTOSINE
RARE BUT DUE TO DECREASED ERGOSTEROL CONTENT
ANY OF THE ENZYME IN THE CONVERSION OF 5-FC to 5FU AND OTHER METABOLITES
AZOLE ANTIFUNGAL
IMIDAZOLE
TRIAZOLE
Azole antifungals are made up of two different classes of drugs—
imidazoles and triazoles. Although these drugs have similar mechanisms
of action and spectra of activity, their pharmacokinetics and therapeutic uses vary significantly.
imidazoles are applied topically for
cutaneous infections
triazoles are administered systemically
for the treatment or prophylaxis of cutaneous and systemic mycoses
MAO AZOLE
Azoles are predominantly fungistatic. They
inhibit 14-α demethylase (a cytochrome P450 [CYP450] enzyme),
thereby blocking the demethylation of lanosterol to ergosterol. The inhibition of ergosterol biosynthesis disrupts
fungal membrane structure and function, which, in turn, inhibits
fungal cell growth